Adverse events following the first, second and third doses of a COVID-19 vaccine in hemodialysis patients

Pai, Mei-FenMei-FenPaiTung, Kuei-TingKuei-TingTungHsu, Shih-PingShih-PingHsuPeng, Yu-SenYu-SenPengWAN-YU LINYang, Ju-YehJu-YehYangWu, Hon-YenHon-YenWuChiu, Yen-LingYen-LingChiuShu, Kai-HsiangKai-HsiangShuTsai, Wan-ChuanWan-ChuanTsai2023-03-212023-03-212023-120886-022Xhttps://scholars.lib.ntu.edu.tw/handle/123456789/629527This study aimed to identify adverse events following the first three doses of COVID-19 vaccines in hemodialysis (HD) patients. Risk factors associated with postvaccination adverse events were explored.enCOVID-19; ChAdOx1; Hemodialysis; adverse event; mRNA-1273; vaccination[SDGs]SDG3Adverse events following the first, second and third doses of a COVID-19 vaccine in hemodialysis patientsjournal article10.1080/0886022X.2023.2172432367154342-s2.0-85147066292WOS:000920146700001https://api.elsevier.com/content/abstract/scopus_id/85147066292